Clinical Trials Search Results

Acute Lymphoblastic Leukemia - Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

Studies how well blinatumomab works compared with standard combination chemotherapy.

Pancreatic Cancer Neoadjuvant - Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer

Combination Chemotherapy With or Without CyberKnife Before Surgery in Treating Patients With Pancreatic Cancer

A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)

Germ Cell Tumors - Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

ALK Positive NSCLC - Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.

DLBCL Relapsed - A Study of Obinutuzumab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

Evaluates the safety, efficacy, and pharmacokinetics of induction treatment with obinutuzumab, polatuzumab vedotin, and venetoclax in participants with relapsed or refractory FL or DLBCL.

HER2 Positive BC - Study of Tucatinib vs Placebo With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer

The purpose of this study is to assess the effect of tucatinib vs. placebo in combination with capecitabine and trastuzumab on progression-free survival (PFS) per RECIST 1.1 based on independent central review.

Learn more at Clinicaltrials.gov NCT02614794